{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T21:12:58Z","timestamp":1768684378691,"version":"3.49.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T00:00:00Z","timestamp":1498089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Graduate Student\u2019s Science Innovation Project of Chongqing","award":["CYS16124"],"award-info":[{"award-number":["CYS16124"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China (NSFC)","doi-asserted-by":"crossref","award":["81372851"],"award-info":[{"award-number":["81372851"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0179680","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T13:40:20Z","timestamp":1498138820000},"page":"e0179680","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Hepatitis B virus reactivation and antiviral prophylaxis during lung cancer chemotherapy: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9691-0049","authenticated-orcid":true,"given":"Yu-tuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiu-song","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilal","family":"Arshad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-nan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-quan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,6,22]]},"reference":[{"issue":"10003","key":"ref1","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"A Schweitzer","year":"2015","journal-title":"The Lancet"},{"issue":"42","key":"ref2","doi-asserted-by":"crossref","first-page":"11941","DOI":"10.3748\/wjg.v21.i42.11941","article-title":"Hepatitis B virus burden in developing countries","volume":"21","author":"R Zampino","year":"2015","journal-title":"World Journal of Gastroenterology"},{"issue":"Suppl 1(Supplement)","key":"ref3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jgh.12220","article-title":"Update on epidemiology of hepatitis B and C in China","volume":"28","author":"Y Cui","year":"2013","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"31","key":"ref4","article-title":"Hepatitis B reactivation in patients with lymphoma: A meta-analysis","volume":"31","author":"L Mozessohn","year":"2013","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"ref5","article-title":"A comparison of entecavir and lamivudine for the prophylaxis of hepatitis B virus reactivation in solid tumor patients undergoing systemic cytotoxic chemotherapy","volume":"10","author":"WC Chen","year":"2015","journal-title":"PLoS ONE"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"SK Sarin","year":"2016","journal-title":"Hepatol Int"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s12032-008-9133-4","article-title":"Chemotherapy-induced Hepatitis B virus reactivation in HbsAg positive cancer patients: A single center experience","volume":"26","author":"OO Eren","year":"2009","journal-title":"Medical Oncology"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-0","article-title":"Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors","volume":"62","author":"W Yeo","year":"2000","journal-title":"J Med Virol"},{"issue":"7","key":"ref9","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/sj.bjc.6601699","article-title":"Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy","volume":"90","author":"W Yeo","year":"2004","journal-title":"Br J Cancer"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12032-014-0119-0","article-title":"Hepatitis B virus reactivation in hepatitis B surface antigen seropositive patients with metastatic non-small cell lung cancer receiving cytotoxic chemotherapy: the efficacy of preemptive lamivudine and identification of risk factors","volume":"31","author":"GN Lin","year":"2014","journal-title":"Medical oncology (Northwood, London, England) [Internet]"},{"issue":"19","key":"ref11","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1200\/JCO.2010.30.0673","article-title":"American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases","volume":"28","author":"AS Artz","year":"2010","journal-title":"J Clin Oncol"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.clinre.2014.07.010","article-title":"Prophylactic lamivudine to improve the outcome of HBsAg-positive lymphoma patients during chemotherapy: A systematic review and meta-analysis","volume":"39","author":"H Li","year":"2015","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7326\/M15-1121","article-title":"Hepatitis b virus reactivation and prophylaxis during solid tumor chemotherapy: A systematic review and meta-analysis","volume":"164","author":"S Paul","year":"2016","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"ref14","article-title":"Prophylactic lamivudine to improve the outcome of breast cancer patients with HBsAg positive during chemotherapy: A meta-analysis","volume":"13","author":"Y Zheng","year":"2013","journal-title":"Hepatitis Monthly"},{"issue":"1","key":"ref15","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"RL Siegel","year":"2016","journal-title":"CA: a cancer journal for clinicians"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-3-319-24223-1_2","article-title":"Epidemiology of Lung Cancer","volume":"893","author":"AG Schwartz","year":"2016","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.bjc.6690652","article-title":"Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours","volume":"81","author":"CG Alexopoulos","year":"1999","journal-title":"British Journal of Cancer"},{"issue":"1","key":"ref18","first-page":"7","article-title":"A clinical study of preventive effect of entecavir on HBV reactivation in lung cancer with HBV carriers after chemotherapy","volume":"28","author":"Che Dehai","year":"2014","journal-title":"Practical Oncology Journal"},{"issue":"8","key":"ref19","first-page":"893","article-title":"The clinical applications of combined HBV approach to chemotherapy for non-small cell lung cancer while adoption of antivirus therapy","volume":"12","author":"L Duan","year":"2009","journal-title":"Chinese Journal of Lung Cancer"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1872-034X.2012.01073.x","article-title":"Managing hepatitis B virus carriers with systemic chemotherapy or biologic therapy in the outpatient clinic","volume":"43","author":"T Nishida","year":"2013","journal-title":"Hepatology Research"},{"issue":"8","key":"ref21","first-page":"465","article-title":"Retrospective analysis of the correlation between hepatitis B Virus infection and chemotherapy-induced hepatic injury in patients with lung cancer","volume":"39","author":"Y Yan","year":"2012","journal-title":"Chinese Journal of Clinical Oncology"},{"issue":"10","key":"ref22","first-page":"771","article-title":"Clinical analysis of application of antiviral drugs in lung cancer patients with hepatitis B virus infection who receiving chemotherapy","volume":"21","author":"L Zheng","year":"2014","journal-title":"Chinese Journal of Cancer Prevention and Treatment"},{"issue":"1","key":"ref23","first-page":"4","article-title":"Effect of entecavir on lung cancer in hepatitis B virus carriers during chemotherapy","author":"Zheng Liang","year":"2016","journal-title":"Medical Journal of Qilu"},{"issue":"15","key":"ref24","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"DF Stroup","year":"2000","journal-title":"Journal of the American Medical Association"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2046-4053-1-2","article-title":"The nuts and bolts of PROSPERO: an international prospective register of systematic reviews","volume":"1","author":"A Booth","year":"2012","journal-title":"Systematic reviews"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"R Dersimonian","year":"1986","journal-title":"Controlled clinical trials"},{"issue":"7109","key":"ref27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"M Egger","year":"1997","journal-title":"BMJ"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.critrevonc.2015.10.017","article-title":"Hepatitis B and cancer: A practical guide for the oncologist","volume":"98","author":"C Bozza","year":"2016","journal-title":"Critical Reviews in Oncology\/hematology"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.21051","article-title":"Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy","volume":"43","author":"W Yeo","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1365-2141.2001.03099.x","article-title":"Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy","volume":"115","author":"G Rossi","year":"2001","journal-title":"British Journal of Haematology"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1038\/bjc.2013.225","article-title":"Hepatitis B virus reactivation risk varies with different chemotherapy regimens commonly used in solid tumours","volume":"108","author":"WH Ling","year":"2013","journal-title":"Br J Cancer"},{"issue":"8","key":"ref32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4254\/wjh.v8.i8.385","article-title":"Management of hepatitis B reactivation in immunosuppressed patients: An update on current recommendations","volume":"8","author":"F Bessone","year":"2016","journal-title":"World journal of hepatology"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: Update 2009","volume":"50","author":"ASF Lok","year":"2009","journal-title":"Hepatology"},{"issue":"S5","key":"ref34","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1002\/hep.22945","article-title":"Reactivation of hepatitis B","volume":"49","author":"JH Hoofnagle","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"Journal of Hepatology"},{"issue":"RR-8","key":"ref36","first-page":"1","article-title":"Recommendations for identification and public health management of persons with chronic hepatitis B virus infection[J]","volume":"57","author":"C M Weinbaum","year":"2008","journal-title":"MMWR Recomm Rep"},{"issue":"24","key":"ref37","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1200\/JCO.2011.35.1635","article-title":"Cost-effectiveness of universal hepatitis B virus screening in patients beginning chemotherapy for solid tumors","volume":"29","author":"FL Day","year":"2011","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/epirev\/mxj009","article-title":"Hepatitis B virus infection: epidemiology and vaccination","volume":"28","author":"CW Shepard","year":"2006","journal-title":"Epidemiologic Reviews"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10549-015-3382-7","article-title":"Hepatitis B virus screening before adjuvant chemotherapy in patients with early-stage breast cancer: a cost-effectiveness analysis","volume":"151","author":"WW Wong","year":"2015","journal-title":"Breast Cancer Res Treat"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0179680","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T12:35:51Z","timestamp":1540298151000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0179680"}},"subtitle":[],"editor":[{"given":"Chiaho","family":"Shih","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,22]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0179680","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,22]]}}}